At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 13, 2026 at 16:00 ET
North Run Capital, LP filed an amended Schedule 13G disclosing beneficial ownership of 3,528,296 shares of TELA Bio common stock, representing 7.8% of shares outstanding as of September 30, 2026. This is an amendment to a prior filing; no prior stake data for North Run is available in the provided documents to determine direction of change. The filing is a routine passive stake update with no material new information.
- North Run Capital, LP and related entities beneficially own 3,528,296 shares of TELA Bio common stock.
- Stake represents 7.8% of outstanding shares as of September 30, 2026.
- Shares held by North Run - Due North Partners, LP, a pooled investment vehicle managed by North Run Capital.
- Filing certifies passive intent under Rule 13d-1(c); securities not held to change or influence control.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access